STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).
We are the voice of the home and specialty infusion
community and the patients we serve
Read More >
Read More >
NHIA represents and advances the interests of organizations that provide infusion and specialized pharmacy services and products to the entire spectrum of home-based patients. In doing so, we consider the provision of cost-effective and high quality medical care to patients undergoing infusion therapy to be of the utmost importance.
As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting the home and specialty infusion field and how to use your voice to advance the industry.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.
Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a
New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home
Donate to the PITCH In Campaign to support NHIA’s Grassroots Efforts
